3000-Person study aims to unlock secrets of immune disorders

NCT ID NCT03610802

Recruiting now Knowledge-focused Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated May 14, 2026 · Updated 20 times

Summary

This study collects blood, saliva, and other samples from up to 3000 people with primary immunodeficiency (PID) or their relatives. The goal is to find genetic causes and better understand these inherited immune disorders. No treatment is given; the focus is on research to improve future diagnosis and care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNODEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Marmara University Hospital, Istanbul Jeffrey Modell Diagnostic and Research Cen
RECRUITING

Istanbul, Turkey (Türkiye)

Contact Phone: •••-•••-•••• Email: •••••@•••••
National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Pavia Hospital (PH)
RECRUITING

Pavia, 27100, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PRIMARY IMMUNODEFICIENCY